Covered recipient · General Payments record
ROBERT WETZEL
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2022–2024
$12,339.10
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $12,000.00 | 9 |
| Food and Beverage | $189.10 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BIOCOMPOSITES INC | $12,004.85 | 10 |
| Lilly USA, LLC | $57.03 | 3 |
| Amgen Inc. | $42.98 | 2 |
| GlaxoSmithKline, LLC. | $31.73 | 2 |
| Exact Sciences Corporation | $30.31 | 1 |
| SANOFI PASTEUR INC. | $22.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $23.48 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116206469 | CMS |
| Amgen Inc. | $19.50 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116206474 | CMS |
| BIOCOMPOSITES INC | $1,000.00 | 03/07/2024 | Consulting Fee | Disputed | 01/23/2026 | 1146435472 | CMS |
| BIOCOMPOSITES INC | $1,875.00 | 04/09/2024 | Consulting Fee | Disputed | 01/23/2026 | 1146435474 | CMS |
| BIOCOMPOSITES INC | $4.85 | 04/29/2024 | Food and Beverage | Disputed | 01/23/2026 | 1146434924 | CMS |
| BIOCOMPOSITES INC | $1,875.00 | 06/04/2024 | Consulting Fee | Disputed | 01/23/2026 | 1146435476 | CMS |
| BIOCOMPOSITES INC | $750.00 | 07/19/2024 | Consulting Fee | Disputed | 01/23/2026 | 1146435478 | CMS |
| BIOCOMPOSITES INC | $1,000.00 | 07/25/2024 | Consulting Fee | Disputed | 01/23/2026 | 1146435480 | CMS |
| BIOCOMPOSITES INC | $1,375.00 | 09/11/2024 | Consulting Fee | Disputed | 01/23/2026 | 1146435482 | CMS |
| BIOCOMPOSITES INC | $1,250.00 | 10/24/2024 | Consulting Fee | Disputed | 01/23/2026 | 1146435484 | CMS |
| BIOCOMPOSITES INC | $1,625.00 | 10/24/2024 | Consulting Fee | Disputed | 01/23/2026 | 1146435486 | CMS |
| BIOCOMPOSITES INC | $1,250.00 | 11/20/2024 | Consulting Fee | Disputed | 01/23/2026 | 1146435488 | CMS |
| Exact Sciences Corporation | $30.31 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114557283 | CMS |
| GlaxoSmithKline, LLC. | $16.18 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116018055 | CMS |
| GlaxoSmithKline, LLC. | $15.55 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116408205 | CMS |
| Lilly USA, LLC | $18.61 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135380110 | CMS |
| Lilly USA, LLC | $20.09 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135390941 | CMS |
| Lilly USA, LLC | $18.33 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135335826 | CMS |
| SANOFI PASTEUR INC. | $22.20 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128731572 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.